KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 122 filers reported holding KURA ONCOLOGY INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $689,250 | -2.8% | 33,475 | +0.7% | 0.00% | – |
Q1 2024 | $709,031 | -86.1% | 33,241 | -90.6% | 0.00% | -100.0% |
Q4 2023 | $5,094,532 | +1662.8% | 354,279 | +1018.0% | 0.00% | – |
Q3 2023 | $288,995 | +0.6% | 31,688 | +16.7% | 0.00% | – |
Q2 2023 | $287,236 | -51.9% | 27,149 | -44.4% | 0.00% | – |
Q1 2023 | $596,873 | +34.0% | 48,804 | +36.0% | 0.00% | – |
Q4 2022 | $445,271 | +22.3% | 35,880 | +34.5% | 0.00% | – |
Q3 2022 | $364,000 | -43.1% | 26,667 | -23.7% | 0.00% | – |
Q2 2022 | $640,000 | +1.3% | 34,936 | -11.1% | 0.00% | – |
Q1 2022 | $632,000 | +6.4% | 39,289 | -7.4% | 0.00% | – |
Q4 2021 | $594,000 | -30.6% | 42,445 | -7.1% | 0.00% | – |
Q3 2021 | $856,000 | -37.8% | 45,674 | -30.8% | 0.00% | -100.0% |
Q2 2021 | $1,376,000 | +8.3% | 65,964 | +46.6% | 0.00% | 0.0% |
Q1 2021 | $1,271,000 | -74.3% | 44,992 | -70.3% | 0.00% | -66.7% |
Q4 2020 | $4,944,000 | +148.9% | 151,367 | +133.5% | 0.00% | +200.0% |
Q3 2020 | $1,986,000 | +94.5% | 64,826 | +3.5% | 0.00% | 0.0% |
Q2 2020 | $1,021,000 | +82.0% | 62,651 | +11.2% | 0.00% | 0.0% |
Q1 2020 | $561,000 | -45.4% | 56,340 | -24.7% | 0.00% | 0.0% |
Q4 2019 | $1,028,000 | -5.3% | 74,810 | +4.4% | 0.00% | 0.0% |
Q3 2019 | $1,086,000 | -28.3% | 71,656 | -7.0% | 0.00% | 0.0% |
Q2 2019 | $1,515,000 | +431.6% | 77,057 | +345.2% | 0.00% | – |
Q1 2019 | $285,000 | +14.9% | 17,307 | -2.3% | 0.00% | – |
Q4 2018 | $248,000 | -92.9% | 17,719 | -91.1% | 0.00% | -100.0% |
Q3 2018 | $3,486,000 | +44.5% | 199,322 | +50.3% | 0.00% | 0.0% |
Q2 2018 | $2,413,000 | +29.5% | 132,645 | +33.4% | 0.00% | 0.0% |
Q1 2018 | $1,863,000 | +127.5% | 99,458 | +85.4% | 0.00% | 0.0% |
Q4 2017 | $819,000 | -72.5% | 53,645 | -73.0% | 0.00% | -50.0% |
Q3 2017 | $2,974,000 | +530.1% | 198,990 | +290.8% | 0.00% | – |
Q2 2017 | $472,000 | +115.5% | 50,913 | +104.2% | 0.00% | – |
Q1 2017 | $219,000 | +338.0% | 24,939 | +191.7% | 0.00% | – |
Q4 2016 | $50,000 | – | 8,551 | +8451.0% | 0.00% | – |
Q3 2016 | $0 | -100.0% | 100 | -92.6% | 0.00% | – |
Q2 2016 | $3,000 | – | 1,352 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |